Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients

NCT04923945 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer Metastatic

Interventions

DRUG: Savolitinib

Sponsor

Hutchison Medipharma Limited